Skip to content
Screener

Viemed Healthcare, Inc. VMD Cash & Equivalents

Cash & Equivalents at other companies

Inogen logo
InogenINGN
$87.28M-15.8%
AdaptHealth logo
AdaptHealthAHCO
$47.96M-10.6%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$2.11M+39.8%
Pulmonx Corporation logo
Pulmonx CorporationLUNG
$61.03M-2.4%
ResMed logo
ResMedRMD
$1.47B+21.5%
Merit Medical Systems logo
Merit Medical SystemsMMSI
$488.08M+23.4%

Other financials

Income statement

See full
Revenue$75.4M+27.5%
Gross profit$42.8M+28.7%
Operating income$4.3M+11.8%
Net income$2.6M-1.6%
EPS (diluted)$0.060.0%

Balance sheet

See full
Total debt$12.4M+84.0%
Total equity$143.9M+6.8%
Total assets$197.4M+10.8%

Cash flow

See full
Operating cash flow$8.1M+183%
CapEx$6.7M-56.6%
Free cash flow$1.4M+111%

Valuation

See full
Market cap$370.6M+25.5%
Enterprise value$373.27M+32.7%
P/E24.9×+3.8×
P/S1.3×+0.1×

Profitability

See full
Gross margin57.6%-1.1pp
Operating margin8.2%-0.2pp
Net margin5.2%-0.1pp
FCF margin9%

Returns & leverage

See full
Return on equity10.7%+0.9pp
Debt / equity0.1×0.0×
Current ratio1.2×-0.2×

Where this comes from

Reported directly by Viemed Healthcare, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The source filing: Viemed Healthcare, Inc.’s 10-Q, filed May 5, 2026.

Filed
May 5, 2026, 5:02 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001729149-26-000029
Line itemNoteThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Net cash used in financing activities$(6,325)$(1,704)
Net decrease in cash and cash equivalents(3,739)(7,380)
Cash and cash equivalents at beginning of year13,50117,540
Cash and cash equivalents at end of period$9,762$10,160
Supplemental disclosures of cash flow information
Cash paid during the period for interest$226$125
Cash paid during the period for income taxes, net of refunds$14$2,957
Supplemental disclosures of non-cash transactions

Item 1. Financial Statements

FAQ

What is Viemed Healthcare, Inc.'s cash & equivalents?
Viemed Healthcare, Inc. (VMD) reported cash & equivalents of $9.76M in Q1 2026.
How has Viemed Healthcare, Inc.'s cash & equivalents changed year-over-year?
Viemed Healthcare, Inc.'s cash & equivalents decreased by 3.9% year-over-year, from $10.16M to $9.76M.
What is the long-term trend for Viemed Healthcare, Inc.'s cash & equivalents?
Over 5 years (2020 to 2025), Viemed Healthcare, Inc.'s cash & equivalents has grown at a -15.3% compound annual growth rate (CAGR), from $30.98M to $13.5M.
What does cash & equivalents mean?
Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

Ask your AI about Viemed Healthcare, Inc.'s cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude